NCT00314119 2026-03-11
Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1
National Institutes of Health Clinical Center (CC)
Completed
Clinical Trials
29 trialsNCT02211768 2025-12-24
Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT03406208 2025-12-24
Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing
Massachusetts General Hospital
Phase NA Completed
NCT03231306 2025-05-02
NF108-BINI
University of Alabama at Birmingham
Phase 2 Completed
NCT05196854 2025-02-24
Clinical Hypnosis and Home Blood Pressure Monitoring in Children With Neurofibromatosis Type 1
Murdoch Childrens Research Institute
Phase NA Completed
NCT01639950 2024-06-21
Validating Pain Scales in Children and Young Adults
National Institutes of Health Clinical Center (CC)
Completed
NCT05438290 2024-05-06
DPCP to Treat Cutaneous Neurofibromas Associated With NF1
Icahn School of Medicine at Mount Sinai
Phase 1 Completed
NCT04474678 2024-01-09
Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!")
Medical University of Vienna
Phase NA Completed
NCT05377008 2023-09-22
OPTIMAL-SSI
Virginia Commonwealth University
Phase NA Completed
NCT02101736 2023-05-24
NF105-CABO
University of Alabama at Birmingham
Phase 2 Completed
NCT01682811 2021-06-18
Phase I Photodynamic Therapy (PDT) for Benign Dermal Neurofibromas (NF1)
Medical College of Wisconsin
Phase 1 Completed
NCT03513757 2020-02-21
Dexmedetomidine and Propofol for Pediatric MRI Sedation
Medical College of Wisconsin
Phase 4 Completed
NCT00824278 2019-12-17
The Use of a Distress Thermometer in a Pediatric Research Setting: An Exploratory Pilot Study
National Institutes of Health Clinical Center (CC)
Completed
NCT01222728 2019-12-17
Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients
National Institutes of Health Clinical Center (CC)
Completed
NCT01633008 2019-09-30
Acceptance and Commitment Therapy for Adolescents and Young Adults With Neurofibromatosis and Chronic Pain
National Institutes of Health Clinical Center (CC)
Phase EARLY_PHASE1 Completed
NCT00303368 2019-02-25
NF1TD
Shriners Hospitals for Children
Completed
NCT02387177 2018-08-17
Resiliency Training for Adolescent Neurofibromatosis Patients Via Videoconferencing With Skype
Massachusetts General Hospital
Phase NA Completed
NCT00021541 2018-04-17
R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT01410006 2017-07-25
NPRI
Washington University School of Medicine
Completed
NCT01140360 2017-07-02
0908-09
Indiana University
Phase 1/2 Completed
NCT01275586 2017-04-12
Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas
Indiana University
Phase EARLY_PHASE1 Completed
NCT02435628 2017-04-04
Relationship Between Psychosocial Factors, Health Literacy, Quality of Life and Satisfaction With Medical Visits in Adults With NF
Massachusetts General Hospital
Completed
NCT02298270 2016-06-23
Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype
Massachusetts General Hospital
Phase NA Completed
NCT00589784 2016-01-25
Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00004437 2015-03-25
Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2
FDA Office of Orphan Products Development
Phase 2 Completed
NCT01412892 2014-11-14
NFitor
Assistance Publique - Hôpitaux de Paris
Phase 2 Completed
NCT00508235 2012-08-01
Quality of Friendships in Children With Neurofibromatosis
M.D. Anderson Cancer Center
Completed
NCT00754780 2012-03-19
Clinical Trial of Pirfenidone in Adult Patients With Neurofibromatosis 1
Mayo Clinic
Phase 2 Completed
NCT01031901 2012-02-27
Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)
The University of Texas Health Science Center, Houston
Phase 1 Completed